Key result
Clinical data registries are increasingly linked to mandated quality reporting and financial incentives, playing a vital role in quality improvement and cost-effectiveness in orthopaedic surgery.
Clinical data registries are increasingly important in orthopaedic surgery for quality improvement, cost-effectiveness research, and compliance with payer mandates.
Answers are grounded in this paper and cite their sources.
May inform orthopaedic quality initiatives; leaves open prospective validation of incentive linkages.
Orthopaedic surgery has historically been a leader in using clinical data registries (CDRs) to improve the effectiveness of care, primarily relating to arthroplasty.The Patient Protection and Affordable Care Act (PPACA) has dramatically altered the quality-reporting landscape in the U.S., and registries are now at the center of several intersecting national health policy initiatives.Moreover, other surgical specialties have established registries with proven success in improving care quality, and lessons can be learned from these efforts.In order to effectively utilize registries for innovation, quality assessment, and demonstration of value, orthopaedic surgeons need a clear understanding of how registries and mandated quality reporting are increasingly linked.CDRs prospectively track outcomes among patients with a unifying disease or treatment.Over the past decade, CDRs have been expanded to include overlapping roles in health services research, quality improvement, and now pay-for-performance initiatives.The Physician Quality Reporting System (PQRS) implemented by the Centers for Medicare &Medicaid Services (CMS) has begun attaching financial incentives to CDR reporting to increase physician participation in national quality-improvement efforts 1 .An up-to-date knowledge of developments in CDR creation and utilization is vitally important for orthopaedic surgeons.CDR participation can meaningfully contribute to increasing value in musculoskeletal care through quality improvement and costeffectiveness research, in addition to complying with payer mandates. An Updat ed Rationale for Regist ry ParticipationThe evolution of CDRs has been shaped by several landmark health-policy changes during the past decade.The Institute of Medicine's reports on patient safety and health-care disparities in the early 2000s forced stakeholders to examine the quality and variability of care delivered to patients 2,3 , while the PPACA brought the issues of cost containment and value to the forefront 4 .Accordingly, the structure and goals of registries have been expanded to meet these objectives.Within orthopaedic surgery, CDRs have historically been used for surveillance of implants, typically in hip and knee arthroplasty.Prospective arthroplasty registries trace their origins to Dr. Mark Coventry of the Mayo Clinic, who started a computerized registry soon after implanting the first Charnley hip arthroplasty in the U.S. in 1969; this registry now includes more than 100,000 total joint procedures, all from the Mayo Clinic 5,6 .Because of the challenge of obtaining longitudinal followup data in a multiple-payer system, much of the pioneering work in orthopaedic registries has since been performed outside the U.S. The first national arthroplasty registries were not created
No takes yet. Share an insight, caveat, or question.
Dy et al. (2016) conducted a review in Orthopaedic surgery. Clinical data registries was evaluated. Clinical data registries are increasingly linked to mandated quality reporting and financial incentives, playing a vital role in quality improvement and cost-effectiveness in orthopaedic surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: